C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/02 (2006.01) A61K 31/47 (2006.01) C07D 217/04 (2006.01) C07D 217/06 (2006.01)
Patent
CA 2136449
2136449 9324461 PCTABS00028 Medicament for oral administration which contains as active substance per individual dose, besides the customary galenic auxiliaries, 10 to 1000 mg of a compound of general formula (I) or (II) in which W is a carbonyl group or a single bond, R1 is a hydrogen atom or a group of the general formula R3CO in which R3 is a lower alkyl, lower alkoxy, mono lower alkylamino or di lower alkylamino group, R2 is an alkyl residue with 3 to 20 carbon atoms which may be branched or unbranched and contain 1 to 3 double bonds, a saturated cycle of 3 to 7 carbon atoms integrated into the chain or as substituent, or may be substituted by one or more aromatic rings or contain an oxygen or sulphur atom, as a racemate and as isolated enantiomers; or the addition salt thereof with a physiologically acceptable acid, and the active substances themselves insofar as they are novel.
Hafner Matthias
Hellendahl Beate
Raschack Manfred
Roehl Franz
Schlecker Rainer
Basf Aktiengesellschaft
Robic
LandOfFree
Tetrahydro- and perhydroisoquinoline derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydro- and perhydroisoquinoline derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydro- and perhydroisoquinoline derivatives and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1815816